MCM
CAPR icon

MAI Capital Management’s Capricor Therapeutics CAPR Stock Holding History

MAI Capital Management’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-832
Closed -$25.3K – 2478
2026
Q1 		$25.3K Buy
832
+480
+136% +$12.8K ﹤0.01% 2651
2025
Q4 		$10.2K Sell
352
-3,680
-91% -$48.1K ﹤0.01% 2839
2025
Q3 		$29.1K Hold
4,032
– – ﹤0.01% 2229
2025
Q2 		$40K Buy
4,032
+400
+11% +$4.22K ﹤0.01% 1986
2025
Q1 		$34.5K Hold
3,632
– – ﹤0.01% 1936
2024
Q4 		$50.1K Buy
+3,632
New +$63.6K ﹤0.01% 1767

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

MAI Capital Management's CAPR Position: Q2 2026 in Review

MAI Capital Management sold out of Capricor Therapeutics (CAPR) in Q2 2026, closing a stake of 832 shares — an estimated $25.3K sold.

MAI Capital Management first reported a position in CAPR in Q4 2024 and held it in 6 quarters. The position peaked at $50.1K in Q4 2024. 169 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • MAI Capital Management reported no remaining Capricor Therapeutics position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 832 Capricor Therapeutics shares in Q2 2026, an estimated $25.3K.
  • MAI Capital Management first reported a position in Capricor Therapeutics in Q4 2024 and held it in 6 quarters.
  • MAI Capital Management's Capricor Therapeutics position peaked at $50.1K in Q4 2024.
  • 169 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.